Please be informed that the Board of Directors of the Company at its meeting held on November 14, 2025 (commenced on 05.30 p.m. and concluded at 06.00 p.m.) has considered and approved ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved unaudited financial results for Q2 and H1 FY26 ended September 30, 2025. The company reported zero revenue from operations, with only Rs 0.54 lakh of other income in Q2 (vs Rs 0.75 lakh in Q2 FY25). Net loss widened slightly to Rs 5.51 lakh in Q2 FY26 (vs Rs 5.05 lakh loss in Q2 FY25); for H1 FY26, loss stood at Rs 13.45 lakh vs Rs 12.88 lakh in H1 FY25. The balance sheet remains deeply stressed: total equity is negative at Rs (2,292.34) lakh against share capital of Rs 285.40 lakh, trade receivables sit at a huge Rs 31,651.99 lakh, and current liabilities of Rs 38,868.80 lakh far exceed current assets. Auditor Bhatter & Associates issued an unqualified limited review report.
Persistent losses, zero operating revenue, and negative shareholders' equity point to serious going concern risks. The stock remains a deep value/distress bet, and investors should watch for any signs of revival, asset sale, or debt restructuring.